Imbruvica (ibrutinib)
pCPA File Number:
20856
Negotiation Status:
Negotiations were not pursued
Indication(s):
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sponsor/Manufacturer:
Janssen Inc.
CDA-AMC Project Number:
PC0082-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: